Clinical and pathologic predictors of complete pathologic response to neoadjuvant docetaxel/anthracycline chemotherapy in breast cancer patients.

被引：0
|
作者：
Coplin, M [1 ]
Naughton, M [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
836
引用
收藏
页码：85S / 85S
页数：1
相关论文
共 50 条
  • [1] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    M Tanioka
    C Shimizu
    K Yonemori
    K Yoshimura
    K Tamura
    T Kouno
    M Ando
    N Katsumata
    H Tsuda
    T Kinoshita
    Y Fujiwara
    [J]. British Journal of Cancer, 2010, 103 : 297 - 302
  • [2] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    Tanioka, M.
    Shimizu, C.
    Yonemori, K.
    Yoshimura, K.
    Tamura, K.
    Kouno, T.
    Ando, M.
    Katsumata, N.
    Tsuda, H.
    Kinoshita, T.
    Fujiwara, Y.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 297 - 302
  • [3] Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Gregor, M. Chavez-Mac
    Brown, E. N.
    Lei, X.
    Hsu, L.
    Meric-Bernstam, F.
    Litton, J.
    Mittendorf, E. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. CANCER RESEARCH, 2010, 70
  • [4] Predictors of Pathologic Complete Response in Axillary Nodes After Neoadjuvant Chemotherapy for Breast Cancer
    Ahn, Soojin
    Romeiser, Jamie
    O'Hea, Brian
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 24 - 25
  • [5] Imaging and Receptor Status as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Fasola, C. E.
    Godette, K. D.
    McDonald, M. W.
    O'Regan, R. M.
    Zelnak, A. B.
    Holmes, L. R.
    Landry, J. C.
    Torres, M. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S210 - S210
  • [6] Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
    Chavez-MacGregor, Mariana
    Brown, Erika
    Lei, Xiudong
    Litton, Jennifer
    Meric-Bernstram, Funda
    Mettendorf, Elizabeth
    Hernandez, Leonel
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana Maria
    [J]. CANCER, 2012, 118 (02) : 326 - 332
  • [7] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
  • [8] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Carolin Müller
    Gilda Schmidt
    Ingolf Juhasz-Böss
    Lisa Jung
    Sarah Huwer
    Erich-Franz Solomayer
    Stephanie Juhasz-Böss
    [J]. Archives of Gynecology and Obstetrics, 2021, 304 : 1065 - 1071
  • [9] Parsing Pathologic Complete Response in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Morrow, Monica
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 516 - 517
  • [10] Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer
    De Iuliis, Francesca
    Salerno, Gerardo
    Corvino, Raffaella
    D'Aniello, Debora
    Cefali, Katia
    Taglieri, Ludovica
    Lanza, Rosina
    Scarpa, Susanna
    [J]. CLINICAL BREAST CANCER, 2017, 17 (01) : 34 - 40
12345